Painaustralia is Australia’s leading pain advocacy body working to improve the quality of life of people living with pain, their families and carers, and to minimise the social and economic burden of pain on individuals and the community.
Media Release
24 September 2025
Painaustralia supports TGA statement on safe use of paracetamol in pregnancy
Painaustralia welcomes and supports the statement from Australia’s Chief Medical Officer and the Therapeutic Goods Administration (TGA) regarding the safe use of paracetamol in pregnancy.
The TGA has confirmed that robust scientific evidence shows no causal link between paracetamol use in pregnancy and the development of autism or ADHD in children. Paracetamol remains the recommended treatment option for fever or pain in pregnancy when used as directed, as untreated pain and fever themselves may pose risks to mother and baby.
2024 Annual Report
June 2025
We are proud to share Painaustralia’s 2024 Annual Report, highlighting a year of renewal, advocacy and impact.
From driving national conversations on pain policy, launching new tools like the Opioid Safety Toolkit and Kaha App, to celebrating excellence through our inaugural Pinnacle Awards - this year’s report captures our continued commitment to amplifying the voices of people living with pain.
Read the full report here and see how we are working to create a more supportive and equitable health system for the 3.7 million Australians affected by chronic pain.

Stay informed
Keep up-to-date with the latest news about pain and from Painaustralia by signing up to our e-newsletter.